Proprietary Medical Device Tech – Innovative Airway Management
Listing Number: 6842-979220
Listing Details
Proprietary Medical Device Tech – Innovative Airway Management
Price: $1
Location: Greater Bridgeport Planning Region, Connecticut
- Down Payment: --
- Sales: $0
- Seller's Discretionary Earnings: $0
- Inventory: $0
- Furniture, Fixtures, and Equipment: $0
- Employees: 0
- Year Established:
- Reason for Selling: Company growth.
For More Information About This Listing
Business Description
Confidential Acquisition Opportunity | Medical Devices / Intellectual Property
An opportunity to acquire a pre-revenue medical device company or its proprietary technology in the established U.S. and international anesthesia and airway management markets.
The company has developed an innovative laryngeal mask airway incorporating a specialized, integrated suctioning system designed to remove secretions that accumulate in the throat while maintaining airway ventilation. This distinctive functionality addresses an important aspect of airway management and offers potential advantages over conventional devices that do not incorporate comparable secretion-removal capabilities.
Multiple generations of the device have been developed and evaluated in published clinical studies involving patients undergoing medical procedures. These studies provide preliminary evidence of successful device placement and secretion removal, supporting further clinical and commercial evaluation.
The technology may be particularly attractive to established medical device manufacturers seeking to differentiate their existing airway product lines, expand their intellectual property portfolios, or accelerate development of next-generation anesthesia products.
Potential acquisition assets include intellectual property rights, product designs, technical documentation, development know-how, and other related assets, subject to verification and due diligence.
The owners are open to discussing either the acquisition of the entire company or a transaction involving its technology and related assets. The business is pre-revenue, with potential commercialization opportunities in the United States and international markets, subject to applicable regulatory requirements.
Serious inquiries from qualified strategic buyers and investors are welcome. Price and additional information will be provided following execution of a confidentiality agreement.
An opportunity to acquire a pre-revenue medical device company or its proprietary technology in the established U.S. and international anesthesia and airway management markets.
The company has developed an innovative laryngeal mask airway incorporating a specialized, integrated suctioning system designed to remove secretions that accumulate in the throat while maintaining airway ventilation. This distinctive functionality addresses an important aspect of airway management and offers potential advantages over conventional devices that do not incorporate comparable secretion-removal capabilities.
Multiple generations of the device have been developed and evaluated in published clinical studies involving patients undergoing medical procedures. These studies provide preliminary evidence of successful device placement and secretion removal, supporting further clinical and commercial evaluation.
The technology may be particularly attractive to established medical device manufacturers seeking to differentiate their existing airway product lines, expand their intellectual property portfolios, or accelerate development of next-generation anesthesia products.
Potential acquisition assets include intellectual property rights, product designs, technical documentation, development know-how, and other related assets, subject to verification and due diligence.
The owners are open to discussing either the acquisition of the entire company or a transaction involving its technology and related assets. The business is pre-revenue, with potential commercialization opportunities in the United States and international markets, subject to applicable regulatory requirements.
Serious inquiries from qualified strategic buyers and investors are welcome. Price and additional information will be provided following execution of a confidentiality agreement.